Lungs And Bronchial Relief

Ammonium Carbonicum, Antimonium Arsenicicum, Antimonium Tartaricum, Arsenicum Album, Bromium, Carbo Vegetabilis, Chlorinum, Kali Carbonicum, Lobelia Inflata, Stannum Metallicum, Sulphuricum Acidum


King Bio Inc.
Human Otc Drug
NDC 57955-2828
Lungs And Bronchial Relief also known as Ammonium Carbonicum, Antimonium Arsenicicum, Antimonium Tartaricum, Arsenicum Album, Bromium, Carbo Vegetabilis, Chlorinum, Kali Carbonicum, Lobelia Inflata, Stannum Metallicum, Sulphuricum Acidum is a human otc drug labeled by 'King Bio Inc.'. National Drug Code (NDC) number for Lungs And Bronchial Relief is 57955-2828. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Lungs And Bronchial Relief drug includes Activated Charcoal - 10 [hp_X]/59mL Ammonium Carbonate - 10 [hp_X]/59mL Antimony Arsenate - 10 [hp_X]/59mL Antimony Potassium Tartrate - 10 [hp_X]/59mL Arsenic Trioxide - 10 [hp_X]/59mL Bromine - 10 [hp_X]/59mL Chlorine - 10 [hp_X]/59mL Lobelia Inflata Whole - 10 [hp_X]/59mL Potassium Carbonate - 10 [hp_X]/59mL Sulfuric Acid - 10 [hp_X]/59mL and more. The currest status of Lungs And Bronchial Relief drug is Active.

Drug Information:

Drug NDC: 57955-2828
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Lungs And Bronchial Relief
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Ammonium Carbonicum, Antimonium Arsenicicum, Antimonium Tartaricum, Arsenicum Album, Bromium, Carbo Vegetabilis, Chlorinum, Kali Carbonicum, Lobelia Inflata, Stannum Metallicum, Sulphuricum Acidum
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: King Bio Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ACTIVATED CHARCOAL - 10 [hp_X]/59mL
AMMONIUM CARBONATE - 10 [hp_X]/59mL
ANTIMONY ARSENATE - 10 [hp_X]/59mL
ANTIMONY POTASSIUM TARTRATE - 10 [hp_X]/59mL
ARSENIC TRIOXIDE - 10 [hp_X]/59mL
BROMINE - 10 [hp_X]/59mL
CHLORINE - 10 [hp_X]/59mL
LOBELIA INFLATA WHOLE - 10 [hp_X]/59mL
POTASSIUM CARBONATE - 10 [hp_X]/59mL
SULFURIC ACID - 10 [hp_X]/59mL
TIN - 10 [hp_X]/59mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 15 Dec, 2021
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 08 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:King Bio Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:2P3VWU3H10
NJ5VT0FKLJ
WE3458XNFT
DL6OZ476V3
S7V92P67HO
SBV4XY874G
4R7X1O2820
9PP1T3TC5U
BQN1B9B9HA
O40UQP6WCF
387GMG9FH5
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
57955-2828-21 BOTTLE, SPRAY in 1 CARTON (57955-2828-2) / 59 mL in 1 BOTTLE, SPRAY15 Dec, 2021N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Equal volumes of each hpus ingredient in 10x, 30x, and 1lm potencies. ammonium carbonicum...............labored breathing, hoarseness antimonium arsenicicum ................................ cough with mucus antimonium tartaricum ..................................... bronchial mucus arsenicum album........................................ wheezing respiration bromium ..................................................... spasmodic coughing carbo vegetabilis........................... coughing attacks with mucus chlorinum ........................................................bronchial irritation kali carbonicum.......................................... wheezing, dry cough lobelia inflata ................................. ringing cough, short breaths stannum metallicum..............................................cough at night sulphuricum acidum.......................................... rapid respiration reference image: lungs.jpg

Product Elements:

Lungs and bronchial relief ammonium carbonicum, antimonium arsenicicum, antimonium tartaricum, arsenicum album, bromium, carbo vegetabilis, chlorinum, kali carbonicum, lobelia inflata, stannum metallicum, sulphuricum acidum ammonium carbonate ammonium cation antimony arsenate arsenate ion antimony potassium tartrate antimony cation (3+) arsenic trioxide arsenic cation (3+) bromine bromine activated charcoal activated charcoal chlorine chlorine potassium carbonate carbonate ion lobelia inflata whole lobelia inflata tin tin sulfuric acid sulfuric acid ascorbic acid citric acid monohydrate citrus aurantium fruit oil orange peel citrus reticulata fruit oil water glycerin lactic acid, unspecified form lonicera japonica flower benzylpenicilloyl polylysine carya ovata bark steviol

Indications and Usage:

Uses for temporary relief of minor symptoms of difficult breathing: lung congestion bronchial inflammation wheezing hoarseness coughing attacks bronchial mucus mucous congestion dry cough as per various homeopathic materia medicas. claims based on traditional homeopathic practice, not accepted medical evidence. these uses have not been evaluated by the fda, and product has not been clinically tested. reference image: lungs.jpg

Warnings:

Warnings stop use and consult a physician if symptoms worsen or persist for more than 7 days. if pregnant or breast-feeding , ask a healthcare professional before use. keep out of reach of children. in case of overdose, get medical help or contact a poison control center immediately. reference image: lungs.jpg

Dosage and Administration:

Directions initially, depress pump until primed. spray one dose directly into mouth. adults: 3 sprays 3 times per day. children ages 6-12: 2 sprays 3 times per day. consult a physician for use in children under 6 years of age. use additionally as needed, up to 6 times per day. reference image: lungs.jpg

Package Label Principal Display Panel:

Image description lungs.jpg


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.